Objective To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. Methods We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC). Results Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2–4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, ...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
Background: ILC is less common than IDC and is usually diagnosed at a later stage Purpose:The aim of...
Background: Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in invasiv...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Invasive lobular carcinoma (ILC) is the most common “special type” of breast cancer. Although confli...
Invasive lobular carcinoma (ILC) is the most common "special type" of breast cancer. Although confli...
BACKGROUND. Although invasive lobular carcinoma (ILC) is the second most common histotype of breast ...
BACKGROUND. Although invasive lobular carcinoma (ILC) is the second most common histotype of breast...
The clinical features of invasive lobular carcinoma (ILC) of the breast have remained unclear due to...
The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltr...
Abstract Background Infiltrating lobular carcinoma (ILC) is the second most common type of invasive ...
BackgroundThe clinical features of invasive lobular carcinoma (ILC) of the breast have remained uncl...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
Abstract Background Although the invasive lobular carcinoma (ILC) is the second most frequent histol...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
Background: ILC is less common than IDC and is usually diagnosed at a later stage Purpose:The aim of...
Background: Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in invasiv...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Invasive lobular carcinoma (ILC) is the most common “special type” of breast cancer. Although confli...
Invasive lobular carcinoma (ILC) is the most common "special type" of breast cancer. Although confli...
BACKGROUND. Although invasive lobular carcinoma (ILC) is the second most common histotype of breast ...
BACKGROUND. Although invasive lobular carcinoma (ILC) is the second most common histotype of breast...
The clinical features of invasive lobular carcinoma (ILC) of the breast have remained unclear due to...
The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltr...
Abstract Background Infiltrating lobular carcinoma (ILC) is the second most common type of invasive ...
BackgroundThe clinical features of invasive lobular carcinoma (ILC) of the breast have remained uncl...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
Abstract Background Although the invasive lobular carcinoma (ILC) is the second most frequent histol...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
Background: ILC is less common than IDC and is usually diagnosed at a later stage Purpose:The aim of...
Background: Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in invasiv...